These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28419094)

  • 21. Developability assessment in pharmaceutical industry: An integrated group approach for selecting developable candidates.
    Saxena V; Panicucci R; Joshi Y; Garad S
    J Pharm Sci; 2009 Jun; 98(6):1962-79. PubMed ID: 18855914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small molecule compound logistics outsourcing--going beyond the "thought experiment".
    Ramsay DL; Kwasnoski JD; Caldwell GW
    Curr Top Med Chem; 2012; 12(11):1298-308. PubMed ID: 22571792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combating the cons of consolidation.
    Nat Rev Drug Discov; 2009 Mar; 8(3):177. PubMed ID: 19263592
    [No Abstract]   [Full Text] [Related]  

  • 25. Making drugs, not profits.
    Stix G
    Sci Am; 2004 May; 290(5):42-4. PubMed ID: 15127660
    [No Abstract]   [Full Text] [Related]  

  • 26. Crowdsourcing in pharma: a strategic framework.
    Bentzien J; Bharadwaj R; Thompson DC
    Drug Discov Today; 2015 Jul; 20(7):874-83. PubMed ID: 25637169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creation of a de novo, pharmaceutical company with a urological bent.
    Wyllie MG
    BJU Int; 2011 Nov; 108(9):E310-1. PubMed ID: 22023062
    [No Abstract]   [Full Text] [Related]  

  • 28. Open access chemical and clinical probes to support drug discovery.
    Edwards AM; Bountra C; Kerr DJ; Willson TM
    Nat Chem Biol; 2009 Jul; 5(7):436-40. PubMed ID: 19536100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic research and development: business as usual?
    Harbarth S; Theuretzbacher U; Hackett J;
    J Antimicrob Chemother; 2015; 70(6):1604-7. PubMed ID: 25673635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous flow synthesis. A pharma perspective.
    Malet-Sanz L; Susanne F
    J Med Chem; 2012 May; 55(9):4062-98. PubMed ID: 22283413
    [No Abstract]   [Full Text] [Related]  

  • 31. Alternative business models for drug discovery.
    Bunin BA; Ekins S
    Drug Discov Today; 2011 Aug; 16(15-16):643-5. PubMed ID: 21745585
    [No Abstract]   [Full Text] [Related]  

  • 32. An unbalanced portfolio.
    Federsel HJ
    Drug News Perspect; 2009 Jun; 22(5):287-92. PubMed ID: 19609466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of crowdsourcing in modern drug discovery.
    Schuhmacher A; Kuss M
    Expert Opin Drug Discov; 2020 Aug; 15(8):865-867. PubMed ID: 32255703
    [No Abstract]   [Full Text] [Related]  

  • 34. An audience with...Sir John Sulston.
    Sulston J
    Nat Rev Drug Discov; 2005 Feb; 4(2):98. PubMed ID: 15756755
    [No Abstract]   [Full Text] [Related]  

  • 35. Could pharma open its drug freezers?
    Mullard A
    Nat Rev Drug Discov; 2011 Jun; 10(6):399-400. PubMed ID: 21629278
    [No Abstract]   [Full Text] [Related]  

  • 36. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
    Betz UA
    Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical Biology Consortium Sweden.
    Hammarström LG; Jensen AJ
    ACS Chem Biol; 2013 Dec; 8(12):2605-6. PubMed ID: 24354290
    [No Abstract]   [Full Text] [Related]  

  • 38. David Haslam. Interview by Asher Mullard.
    Haslam D
    Nat Rev Drug Discov; 2013 Jul; 12(7):500. PubMed ID: 23764976
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.
    Gromo G; Mann J; Fitzgerald JD
    Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to help the free market fight coronavirus.
    Burley SK
    Nature; 2020 Apr; 580(7802):167. PubMed ID: 32210376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.